No Need For Routine GCP Compliance Reports, UK MHRA Tells Pharma
This article was originally published in SRA
Executive Summary
Pharmaceutical companies and other organizations that conduct clinical trials in the UK no longer have to submit good clinical practice (GCP) compliance reports to the Medicines and Healthcare products Regulatory Agency on a routine basis to support the regulator's risk-based GCP inspections program1.